Background The Food Safety and Standard (Labelling and Display) First Amendment Regulation, 2026 were notified by FSSAI on March 24, 2026 to amend the existing Food Safety And Standards (Labelling And Display) 2020. The Amendment aims to simplify certain labelling requirements while improving clarity and traceability. It introduces relaxations for infant nutrition products and small packages, clarifies […]
Generative Artificial Intelligence (“GenAI”) is moving beyond chatbots and large language models (“LLMs”) into multimodal systems, reasoning models, agentic AI, semiconductor infrastructure, data centres, energy systems and sector-specific applications. WIPO’s recent analysis, “Beyond the Chatbot: What Patent Data Reveals About the Next Phase of GenAI,” captures this shift through global patent activity. [1] The numbers are striking: published GenAI patent families increased […]
The Delhi High Court’s decision in Columbia Pictures Industries, Inc. v. Registrar of Trade Marks & Anr., C.A. (COMM. IPD-TM) 44/2025, decided on 6 July 2026, addresses an important question concerning the protection of well-known trademarks in India: whether a trademark must first be formally declared “well known” under Rule 124 of the Trade Marks […]
Introduction The rapid growth of Artificial Intelligence (AI), machine learning, and data-driven technologies has increased the significance of “black box” software systems. A black box algorithm is generally understood as a computational model where the inputs and outputs are known, but the internal decision-making process is either opaque or not readily understandable. While such technologies have […]
The Delhi High Court’s decision in Array Biopharma Inc. v. Deputy Controller of Patents and Designs [C.A.(COMM.IPD-PAT) 37/2023] provides significant guidance on inventive step, the exclusions under Sections 3(d) and Section 3(i) of the Patent Act, and the standard of reasoning expected from the Patent Office when refusing combination patents involving multiple independently known active […]
The Delhi High Court’s decision in Intra-Cellular Therapies, Inc. v. The Controller of Patents [C.A.(COMM.IPD-PAT) 24/2023], provides significant guidance on novelty, inventive step and the enhanced efficacy requirement under Section 3(d) of the Patents Act, 1970. The judgment is particularly relevant to pharmaceutical inventions involving modifications of known compounds and the evidentiary burden required to […]
Influencer advertising is now a central part of India’s advertising ecosystem. As influencers increasingly become the face of commercial campaigns, questions of advertising compliance have followed. Recent data from the Advertising Standards Council of India (ASCI) illustrates the scale of the concern: of the 37,532 advertising violation cases processed by ASCI, 21.12% involved influencer violations. […]
“100% Pure” sounds reassuring. For a consumer, it may suggest that a product is natural, completely pure and free from anything that might compromise its quality. But in advertising law, absolute claims invite close scrutiny: can the advertiser substantiate the claim, and is the overall consumer impression accurate? These questions came before the Delhi High […]
KAN & KRISHME is pleased to announce its participation in the 2026 AIPPI World Congress, taking place from 6–10 October 2026 in Hamburg, Germany. The AIPPI World Congress is one of the leading international gatherings for intellectual property professionals, bringing together IP practitioners, experts, policymakers, in-house counsel, and industry leaders from around the world. The […]
For over two decades, Crocs’ iconic perforated clogs have been recognised worldwide for their distinctive appearance. Their unique shape became synonymous with the brand, making them an obvious subject for IP protection. Recently, in Crocs Inc. USA v. Bata India Ltd. [CS(COMM) 625/2018] the Delhi High Court directed Crocs to pay USD 25,812 (₹24.63 lakh) […]









